Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C8H14N2O |
| Molecular Weight | 154.2096 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CO\N=C\C1=CCCN(C)C1
InChI
InChIKey=YMMXHEYLRHNXAB-RMKNXTFCSA-N
InChI=1S/C8H14N2O/c1-10-5-3-4-8(7-10)6-9-11-2/h4,6H,3,5,7H2,1-2H3/b9-6+
| Molecular Formula | C8H14N2O |
| Molecular Weight | 154.2096 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Milameline (previously known as RU 35926/CI-979), a partial muscarinic agonist that was developed as a cognition-enhancing agent for the treatment of patients with Alzheimer's disease. In spite of this drug has achieved phase III clinical trials, further studies were apparently discontinued.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Combined cerebral blood flow effects of a cholinergic agonist (milameline) and a verbal recognition task in early Alzheimer's disease. | 2006-10 |
|
| Preclinical and phase 1 clinical characterization of CI-979/RU35926, a novel muscarinic agonist for the treatment of Alzheimer's disease. | 1995 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10188788
CI-979/RU35926 (milameline) was well tolerated at doses of 0.002-1.0 mg with cholinergic symptoms such as hypersalivation and sweating, observed at 2-4 mg.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:17:19 GMT 2025
by
admin
on
Mon Mar 31 19:17:19 GMT 2025
|
| Record UNII |
R9X77R42FN
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C47796
Created by
admin on Mon Mar 31 19:17:19 GMT 2025 , Edited by admin on Mon Mar 31 19:17:19 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
139886-32-1
Created by
admin on Mon Mar 31 19:17:19 GMT 2025 , Edited by admin on Mon Mar 31 19:17:19 GMT 2025
|
PRIMARY | |||
|
SUB08961MIG
Created by
admin on Mon Mar 31 19:17:19 GMT 2025 , Edited by admin on Mon Mar 31 19:17:19 GMT 2025
|
PRIMARY | |||
|
R9X77R42FN
Created by
admin on Mon Mar 31 19:17:19 GMT 2025 , Edited by admin on Mon Mar 31 19:17:19 GMT 2025
|
PRIMARY | |||
|
DTXSID401028867
Created by
admin on Mon Mar 31 19:17:19 GMT 2025 , Edited by admin on Mon Mar 31 19:17:19 GMT 2025
|
PRIMARY | |||
|
100000080612
Created by
admin on Mon Mar 31 19:17:19 GMT 2025 , Edited by admin on Mon Mar 31 19:17:19 GMT 2025
|
PRIMARY | |||
|
Milameline
Created by
admin on Mon Mar 31 19:17:19 GMT 2025 , Edited by admin on Mon Mar 31 19:17:19 GMT 2025
|
PRIMARY | |||
|
9571002
Created by
admin on Mon Mar 31 19:17:19 GMT 2025 , Edited by admin on Mon Mar 31 19:17:19 GMT 2025
|
PRIMARY | |||
|
C132273
Created by
admin on Mon Mar 31 19:17:19 GMT 2025 , Edited by admin on Mon Mar 31 19:17:19 GMT 2025
|
PRIMARY | |||
|
7401
Created by
admin on Mon Mar 31 19:17:19 GMT 2025 , Edited by admin on Mon Mar 31 19:17:19 GMT 2025
|
PRIMARY | |||
|
C084978
Created by
admin on Mon Mar 31 19:17:19 GMT 2025 , Edited by admin on Mon Mar 31 19:17:19 GMT 2025
|
PRIMARY | |||
|
CHEMBL151938
Created by
admin on Mon Mar 31 19:17:19 GMT 2025 , Edited by admin on Mon Mar 31 19:17:19 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> AGONIST |
|
||
|
TARGET -> AGONIST |
|
||
|
TARGET -> AGONIST |
|
||
|
TARGET -> AGONIST |
|
||
|
TARGET -> AGONIST |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|